PPARG: A Promising Therapeutic Target in Breast Cancer and Regulation by Natural Drugs

Table 1

PPARG expression levels in BC patients in relation to clinicopathological characteristics.

	Clinicopathological characteristics	High expression group	Low expression group	-Value
Status	Alive	480	467	0.333
	Dead	71	83
Age	Mean (SD)	57.6 (13)	59.1 (13.4)	0.069
	Median [Min, Max]	58 [26, 90]	59 [26, 90]
Gender	Female	546	543	0.769
	Male	5	7
pT-stage	TX	0	3	0.007
	T1	161	120
	T2	292	347
	T3	83	55
	T4	15	25
pN-stage	NX	7	13	0.173
	N0	252	264
	N1	187	179
	N2	56	64
	N3	49	30
pM-stage	MX	86	77	0.182
	M0	455	455
	M1	7	15
pTNM-stage	X	5	8	0.041
	I	102	80
	II	296	328
	III	136	115
	IV	6	14